|
|
 |
| |
|
Home > Drug Companies > McNeil Consumer Healthcare
McNeil Consumer Healthcare
McNeil Consumer Healthcare, Canada, is committed to providing value-added products and services as well as environmental leadership and global sustainability. Its nonprescription pharmaceuticals include complete lines of Tylenol and Motrin for adults and children.
Their units' global research, development and marketing operations help to form an integrated enterprise that is well positioned to deliver biotechnology's extraordinary promise to patients and physicians around the world. They have made a vigorous commitment to create an environment in which innovation flourishes throughout their companies around the world.
The Pharmaceutical Pipeline shows a selection of key drugs in late stages of development or pending registration in the U.S. by one of their operating companies. This list is not meant to be exhaustive, and the products shown here are intended for use by patients in the U.S. only. Some of these products may already be marketed in countries outside the U.S., or may be under consideration for development in other countries.
World leadership includes elimination of injuries and illnesses, globally sharing their best practices and success stories, anticipating and influencing the worldwide regulatory environment, driving business results, establishing health and safety as a value and affirming that safety is good business.
The firm is focused on establishing itself as a high profile, quality provider of unique, niche pharmaceuticals in four therapeutic areas neonatology, oncology, endocrinology and cardiology and will continue to acquire new products for commercialization. Several promising, novel candidates have been identified and the company is progressing toward such acquisitions. The objective of the company is to develop late stage, patented drugs intended for specialty or niche markets. The intent is to self fund the development of these products from revenues generated by product sales.
Back to Drug Companies
|
|
|
|
|
|
|
|